Cannabidiol in Dietary Supplements: Characteristics, Routes of Administration, Bioavailability, and Research Challenges
Molecules · 2026
DOI: 10.3390/molecules31132385 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2026. Verfasst von Angelika Talar-Śpionek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Safety and Chemical Analysis, Prof. Wacław Dąbrowski Institute of Agricultural and Food Biotechnology-State Research Institute, 36…. Hauptthemen laut MEDLINE: Cannabidiol, Dietary Supplements. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education, Ministry of Science and Higher Education, Poland.
Abstract (Originalsprache)
Cannabidiol (CBD) has gained increasing attention as an ingredient in dietary supplements and functional foods due to its potential health-promoting properties. As a major non-psychoactive phytocannabinoid derived from Cannabis sativa L., CBD has been associated with anti-inflammatory, antioxidant, and neuroprotective effects. However, its application in nutraceutical products remains challenging because of its low and variable oral bioavailability, limited long-term safety data, and ongoing regulatory requirements. In the European Union (EU), CBD-containing products are classified as Novel Foods and require a comprehensive safety assessment before market authorisation. This review summarises current knowledge on CBD in dietary supplements, providing an overview of its chemical characteristics, routes of administration, and the key factors influencing its absorption and pharmacokinetics. It also reviews the main CBD formulations available in dietary supplements, including oils, capsules, gummies, and e-liquids, with particular emphasis on their characteristics relevant to CBD stability and bioavailability, as well as current regulatory frameworks. Finally, the major scientific and technological challenges associated with CBD-containing dietary supplements are highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Safety and Chemical Analysis, Prof. Wacław Dąbrowski Institute of Agricultural and Food Biotechnology-State Research Institute, 36 Rakowiecka Street, 02-532 Warsaw, Poland.
- Department of Biotechnology, Prof. Wacław Dąbrowski Institute of Agricultural and Food Biotechnology-State Research Institute, 36 Rakowiecka Street, 02-532 Warsaw, Poland.
ORCID-Profile: Edyta Juszczuk-Kubiak, Marek Roszko
Förderung
- Ministry of Science and Higher Education
- Ministry of Science and Higher Education, Poland
Zitieren
APA
Talar-Śpionek, A., Juszczuk-Kubiak, E., & Roszko, M. (2026). Cannabidiol in Dietary Supplements: Characteristics, Routes of Administration, Bioavailability, and Research Challenges. Molecules. https://doi.org/10.3390/molecules31132385
Vancouver
Talar-Śpionek A, Juszczuk-Kubiak E, Roszko M. Cannabidiol in Dietary Supplements: Characteristics, Routes of Administration, Bioavailability, and Research Challenges. Molecules. 2026. doi:10.3390/molecules31132385
BibTeX
@article{Talarpionek2026,
author = {Talar-Śpionek, Angelika and Juszczuk-Kubiak, Edyta and Roszko, Marek},
title = {Cannabidiol in Dietary Supplements: Characteristics, Routes of Administration, Bioavailability, and Research Challenges},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31132385}
}
EUVIMED